Regenacy Pharmaceuticals
PrivateLast Round
Series B
Aug 24, 2022
Total Funding Raised
$39.3M
Company Overview
Regenacy Pharmaceuticals is a biopharmaceutical company that develops innovative therapeutic drugs using a novel, disease-modifying approach to treat peripheral neuropathy and related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenacy Pharmaceuticals Comparables
Compare Regenacy Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Augustine Therapeutics | 91% | |
| Novaremed AG | 83% | |
| WinSanTor | 81% |
Regenacy Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 24, 2022 | ||||
| Series A | Mar 25, 2020 |
Regenacy Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series B, Series A |
| Bencao Capital | Series A, Series B |
| Yonjin Capital | Series A |
| Viva Biotech | Series A |
| TA YA VENTURE HOLDINGS LIMITED | Series A |
| Yonjin Capital | Series A |
| Cobro Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2022
$9.3M round led by Cobro Ventures.
Regenacy Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Regenacy Pharmaceuticals's valuation, stock price, and market status.
Is Regenacy a public or private company?
Regenacy is a private company.
What is the current stock price of Regenacy?
Regenacy is a private company with no public stock price. No recent secondary market data is available.
How much is Regenacy worth (valuation)?
Valuation information for Regenacy is not publicly available.
Can I buy Regenacy stock?
Regenacy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Regenacy's last funding round?
Regenacy's most recent funding round was Series B on August 24, 2022.
Who are the main investors in Regenacy?
Key investors in Regenacy include Cobro Ventures.
Will Regenacy IPO soon?
No public IPO plans have been announced for Regenacy.
How can I track Regenacy secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Regenacy's secondary market activity and sign up for updates.